BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9934934)

  • 1. Clinical efficacy of milbemycin oxime in the treatment of nasal mite infection in dogs.
    Gunnarsson LK; Möller LC; Einarsson AM; Zakrisson G; Hagman BG; Christensson DA; Uggla AH; Hedhammar AA
    J Am Anim Hosp Assoc; 1999; 35(1):81-4. PubMed ID: 9934934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of milbemycin oxime in the treatment of dogs with nasal mite (Pneumonyssoides caninum) infection.
    Bredal W; Vollset I
    J Small Anim Pract; 1998 Mar; 39(3):126-30. PubMed ID: 9551380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological survey of therapy and diagnostic procedures used by Norwegian small animal practitioners in cases of nasal mite (Pneumonyssoides caninum) infection in dogs.
    Bredal WP
    Vet Res Commun; 1998 Sep; 22(6):389-99. PubMed ID: 9810635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of milbemycin oxime in the treatment of generalized demodicosis in adult dogs.
    Miller WH; Scott DW; Wellington JR; Panić R
    J Am Vet Med Assoc; 1993 Nov; 203(10):1426-9. PubMed ID: 8276701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of increased dosages of milbemycin oxime for treatment of generalized demodicosis in adult dogs.
    Miller WH; Scott DW; Cayatte SM; Buerger RG; Bagladi MS
    J Am Vet Med Assoc; 1995 Dec; 207(12):1581-4. PubMed ID: 7493895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of canine sarcoptic mange using milbemycin oxime: a correction.
    de Jaham C
    Can Vet J; 1995 Aug; 36(8):467. PubMed ID: 7585429
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of selamectin in the treatment of nasal mite (Pneumonyssoides caninum) infection in dogs.
    Gunnarsson L; Zakrisson G; Christensson D; Uggla A
    J Am Anim Hosp Assoc; 2004; 40(5):400-4. PubMed ID: 15347620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Pneumonyssoides caninum infection in dogs in Sweden.
    Gunnarsson LK; Zakrisson G; Egenvall A; Christensson DA; Uggla A
    J Am Anim Hosp Assoc; 2001; 37(4):331-7. PubMed ID: 11450833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of milbemycin oxime in the treatment of canine generalized demodicosis: a retrospective study of 99 dogs (1995-2000).
    Holm BR
    Vet Dermatol; 2003 Aug; 14(4):189-95. PubMed ID: 12895223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic findings, sensitivity to house dust mites and efficacy of milbemycin oxime treatment of dogs with Cheyletiella sp. infestation.
    White SD; Rosychuk RA; Fieseler KV
    Vet Dermatol; 2001 Feb; 12(1):13-8. PubMed ID: 11301534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposed new therapeutic protocol for the treatment of canine mange with ivermectin.
    Mueller RS; Bettenay SV
    J Am Anim Hosp Assoc; 1999; 35(1):77-80. PubMed ID: 9934933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
    Heine J; Krieger K; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of nasal mite (Pneumonyssoides caninum) infection in Norwegian dogs.
    Bredal WP
    Vet Parasitol; 1998 Apr; 76(3):233-7. PubMed ID: 9615957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of milbemycin oxime against Ancylostoma caninum in dogs with naturally acquired infection.
    Wade CG; Mercer SH; Hepler DI; Craig TM
    Am J Vet Res; 1991 Jun; 52(6):951-3. PubMed ID: 1883101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for generalized canine demodicosis.
    Charach MG
    Can Vet J; 1995 Nov; 36(11):721. PubMed ID: 8590432
    [No Abstract]   [Full Text] [Related]  

  • 17. New approaches to the treatment of canine demodicosis.
    Paradis M
    Vet Clin North Am Small Anim Pract; 1999 Nov; 29(6):1425-36. PubMed ID: 10563009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intravenous and oral pharmacokinetics of afoxolaner and milbemycin oxime when used as a combination chewable parasiticide for dogs.
    Letendre L; Harriman J; Drag M; Mullins A; Malinski T; Rehbein S
    J Vet Pharmacol Ther; 2017 Jan; 40(1):35-43. PubMed ID: 27604405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of canine adult-onset demodicosis.
    Shaw SE; Foster AP
    Aust Vet J; 2000 Apr; 78(4):243-4. PubMed ID: 10840567
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced gastrointestinal nematode infections in dogs.
    Fankhauser R; Hamel D; Dorr P; Reinemeyer CR; Crafford D; Bowman DD; Ulrich M; Yoon S; Larsen DL
    Vet Parasitol; 2016 Jul; 225():117-22. PubMed ID: 27369586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.